[Bucco-dental manifestations of neuropsychotropic drugs. (Clinical review and preliminary results of a mycological and biochemical study of buccal environment)].
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects*; D002176:Candida albicans / Q000302:isolation & purification; D003731:Dental Caries / Q000139:chemically induced*; D004285:Dogs; D005260:Female; D005882:Gingival Diseases / Q000139:chemically induced; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D066298:In Vitro Techniques; D008047:Lip Diseases / Q000139:chemically induced; D008297:Male; D009055:Mouth / Q000382:microbiology; D009059:Mouth Diseases / Q000139:chemically induced* / Q000188:drug therapy; D009061:Mouth Mucosa / Q000187:drug effects; D051381:Rats; D012463:Saliva / Q000032:analysis; D014149:Tranquilizing Agents / Q000009:adverse effects*; D015003:Yeasts / Q000302:isolation & purification
D000928:Antidepressive Agents; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents
Manifestations bucco-dentaires de médicaments neuroi-psychotropes. (Rappel clinique et premiers résultats d'uneétude mycologique et biochimique du milieu buccal.